Analgesics is achieving only small positive value growth in Spain in 2024, due to a confluence of factors suppressing potential sales. Whilst analgesics is a large category in OTC and sees stable baseline demand overall, we note fewer incidences of influenza or COVID-19 in the past year than seen during the pandemic era (especially) and in the following period, as people were initially more susceptible to picking up viruses after the era of seclusion. This has affected the level of demand for an...
Euromonitor International's Analgesics in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Analgesics market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Analgesics in Spain
Euromonitor International
September 2024
List Of Contents And Tables
ANALGESICS IN SPAIN
KEY DATA FINDINGS
2024 DEVELOPMENTS
Fewer viruses and consumers opting for Rx lead to low positive sales
Negative reports surrounding Nolotil help boost sales of other analgesics
Brand rankings remain unchanged amid new product launches
PROSPECTS AND OPPORTUNITIES
Steady growth anticipated for the forecast years, thanks to baseline demand
Segmentation activity will continue to focus on sport-related injuries, but there are other areas to explore
New strategy to address supply shortages expected to help forecast growth
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2019-2024
Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN SPAIN
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2019-2024
Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification